203 related articles for article (PubMed ID: 3917409)
1. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
[TBL] [Abstract][Full Text] [Related]
2. The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.
Klijn JG; Lamberts SW; de Jong FH; Birkenhäger JC
Fertil Steril; 1981 Feb; 35(2):155-61. PubMed ID: 6781936
[TBL] [Abstract][Full Text] [Related]
3. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
4. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
[TBL] [Abstract][Full Text] [Related]
5. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
7. Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Barbarino A; De Marinis L; Mancini A; Menini E; D'Amico C; Passeri M; Sambo P; Anile C; Maira G
Acta Endocrinol (Copenh); 1985 Sep; 110(1):10-6. PubMed ID: 3929517
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
Shangold GA; Kletzky OA; Marrs RP; Mishell DR
Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
[TBL] [Abstract][Full Text] [Related]
12. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
Arafah BM; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
[TBL] [Abstract][Full Text] [Related]
15. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
[TBL] [Abstract][Full Text] [Related]
16. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
[TBL] [Abstract][Full Text] [Related]
17. Lack of plasma prolactin response to intravenously injected vasoactive intestinal polypeptide in patients with prolactin-secreting adenoma.
Kaji H; Chihara K; Kita T; Kashio Y; Okimura Y; Fujita T
Acta Endocrinol (Copenh); 1985 Dec; 110(4):445-50. PubMed ID: 4090907
[TBL] [Abstract][Full Text] [Related]
18. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
Marrs RP; Bertolli SJ; Kletzky OA
Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
[TBL] [Abstract][Full Text] [Related]
19. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
20. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Brismar K
Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
